United States Dabigatran Etexilate Market Report 2017

August 2017 | 95 pages | ID: UD741C7AA14EN
QYResearch

Abstracts

In this report, the United States Dabigatran Etexilate market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Dabigatran Etexilate in these regions, from 2012 to 2022 (forecast).

United States Dabigatran Etexilate market competition by top manufacturers/players, with Dabigatran Etexilate sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Boehringer Ingelheim
• Glenmark Pharms
• Teva Pharms USA

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• 75 mg Capsule
• 110 mg Capsule
• 150 mg Capsule

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Dabigatran Etexilate for each application, including

• Hospital
• Pharmacy
• Clinic

Contents

United States Dabigatran Etexilate Market Report 2017

1 DABIGATRAN ETEXILATE OVERVIEW

1.1 Product Overview and Scope of Dabigatran Etexilate
1.2 Classification of Dabigatran Etexilate by Product Category
  1.2.1 United States Dabigatran Etexilate Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Dabigatran Etexilate Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 75 mg Capsule
  1.2.4 110 mg Capsule
  1.2.5 150 mg Capsule
1.3 United States Dabigatran Etexilate Market by Application/End Users
  1.3.1 United States Dabigatran Etexilate Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Pharmacy
  1.3.4 Clinic
1.4 United States Dabigatran Etexilate Market by Region
  1.4.1 United States Dabigatran Etexilate Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Dabigatran Etexilate Status and Prospect (2012-2022)
  1.4.3 Southwest Dabigatran Etexilate Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Dabigatran Etexilate Status and Prospect (2012-2022)
  1.4.5 New England Dabigatran Etexilate Status and Prospect (2012-2022)
  1.4.6 The South Dabigatran Etexilate Status and Prospect (2012-2022)
  1.4.7 The Midwest Dabigatran Etexilate Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Dabigatran Etexilate (2012-2022)
  1.5.1 United States Dabigatran Etexilate Sales and Growth Rate (2012-2022)
  1.5.2 United States Dabigatran Etexilate Revenue and Growth Rate (2012-2022)

2 UNITED STATES DABIGATRAN ETEXILATE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Dabigatran Etexilate Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Dabigatran Etexilate Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Dabigatran Etexilate Average Price by Players/Suppliers (2012-2017)
2.4 United States Dabigatran Etexilate Market Competitive Situation and Trends
  2.4.1 United States Dabigatran Etexilate Market Concentration Rate
  2.4.2 United States Dabigatran Etexilate Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Dabigatran Etexilate Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES DABIGATRAN ETEXILATE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Dabigatran Etexilate Sales and Market Share by Region (2012-2017)
3.2 United States Dabigatran Etexilate Revenue and Market Share by Region (2012-2017)
3.3 United States Dabigatran Etexilate Price by Region (2012-2017)

4 UNITED STATES DABIGATRAN ETEXILATE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Dabigatran Etexilate Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Dabigatran Etexilate Revenue and Market Share by Type (2012-2017)
4.3 United States Dabigatran Etexilate Price by Type (2012-2017)
4.4 United States Dabigatran Etexilate Sales Growth Rate by Type (2012-2017)

5 UNITED STATES DABIGATRAN ETEXILATE SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Dabigatran Etexilate Sales and Market Share by Application (2012-2017)
5.2 United States Dabigatran Etexilate Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES DABIGATRAN ETEXILATE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Boehringer Ingelheim
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Dabigatran Etexilate Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Boehringer Ingelheim Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Glenmark Pharms
  6.2.2 Dabigatran Etexilate Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Glenmark Pharms Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Teva Pharms USA
  6.3.2 Dabigatran Etexilate Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Teva Pharms USA Dabigatran Etexilate Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview

7 DABIGATRAN ETEXILATE MANUFACTURING COST ANALYSIS

7.1 Dabigatran Etexilate Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Dabigatran Etexilate

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Dabigatran Etexilate Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Dabigatran Etexilate Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES DABIGATRAN ETEXILATE MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Dabigatran Etexilate Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Dabigatran Etexilate Sales Volume Forecast by Type (2017-2022)
11.3 United States Dabigatran Etexilate Sales Volume Forecast by Application (2017-2022)
11.4 United States Dabigatran Etexilate Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Dabigatran Etexilate
Figure United States Dabigatran Etexilate Market Size (K Units) by Type (2012-2022)
Figure United States Dabigatran Etexilate Sales Volume Market Share by Type (Product Category) in 2016
Figure 75 mg Capsule Product Picture
Figure 110 mg Capsule Product Picture
Figure 150 mg Capsule Product Picture
Figure United States Dabigatran Etexilate Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Dabigatran Etexilate by Application in 2016
Figure Hospital Examples
Figure Pharmacy Examples
Figure Clinic Examples
Figure United States Dabigatran Etexilate Market Size (Million USD) by Region (2012-2022)
Figure The West Dabigatran Etexilate Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Dabigatran Etexilate Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Dabigatran Etexilate Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Dabigatran Etexilate Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Dabigatran Etexilate Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Dabigatran Etexilate Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Dabigatran Etexilate Sales (K Units) and Growth Rate (2012-2022)
Figure United States Dabigatran Etexilate Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Dabigatran Etexilate Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Dabigatran Etexilate Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Dabigatran Etexilate Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Dabigatran Etexilate Sales Share by Players/Suppliers
Figure 2017 United States Dabigatran Etexilate Sales Share by Players/Suppliers
Figure United States Dabigatran Etexilate Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Dabigatran Etexilate Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Dabigatran Etexilate Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Dabigatran Etexilate Revenue Share by Players/Suppliers
Figure 2017 United States Dabigatran Etexilate Revenue Share by Players/Suppliers
Table United States Market Dabigatran Etexilate Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Dabigatran Etexilate Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Dabigatran Etexilate Market Share of Top 3 Players/Suppliers
Figure United States Dabigatran Etexilate Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Dabigatran Etexilate Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Dabigatran Etexilate Product Category
Table United States Dabigatran Etexilate Sales (K Units) by Region (2012-2017)
Table United States Dabigatran Etexilate Sales Share by Region (2012-2017)
Figure United States Dabigatran Etexilate Sales Share by Region (2012-2017)
Figure United States Dabigatran Etexilate Sales Market Share by Region in 2016
Table United States Dabigatran Etexilate Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Dabigatran Etexilate Revenue Share by Region (2012-2017)
Figure United States Dabigatran Etexilate Revenue Market Share by Region (2012-2017)
Figure United States Dabigatran Etexilate Revenue Market Share by Region in 2016
Table United States Dabigatran Etexilate Price (USD/Unit) by Region (2012-2017)
Table United States Dabigatran Etexilate Sales (K Units) by Type (2012-2017)
Table United States Dabigatran Etexilate Sales Share by Type (2012-2017)
Figure United States Dabigatran Etexilate Sales Share by Type (2012-2017)
Figure United States Dabigatran Etexilate Sales Market Share by Type in 2016
Table United States Dabigatran Etexilate Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Dabigatran Etexilate Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Dabigatran Etexilate by Type (2012-2017)
Figure Revenue Market Share of Dabigatran Etexilate by Type in 2016
Table United States Dabigatran Etexilate Price (USD/Unit) by Types (2012-2017)
Figure United States Dabigatran Etexilate Sales Growth Rate by Type (2012-2017)
Table United States Dabigatran Etexilate Sales (K Units) by Application (2012-2017)
Table United States Dabigatran Etexilate Sales Market Share by Application (2012-2017)
Figure United States Dabigatran Etexilate Sales Market Share by Application (2012-2017)
Figure United States Dabigatran Etexilate Sales Market Share by Application in 2016
Table United States Dabigatran Etexilate Sales Growth Rate by Application (2012-2017)
Figure United States Dabigatran Etexilate Sales Growth Rate by Application (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Dabigatran Etexilate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Dabigatran Etexilate Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim Dabigatran Etexilate Sales Market Share in United States (2012-2017)
Figure Boehringer Ingelheim Dabigatran Etexilate Revenue Market Share in United States (2012-2017)
Table Glenmark Pharms Basic Information List
Table Glenmark Pharms Dabigatran Etexilate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Glenmark Pharms Dabigatran Etexilate Sales Growth Rate (2012-2017)
Figure Glenmark Pharms Dabigatran Etexilate Sales Market Share in United States (2012-2017)
Figure Glenmark Pharms Dabigatran Etexilate Revenue Market Share in United States (2012-2017)
Table Teva Pharms USA Basic Information List
Table Teva Pharms USA Dabigatran Etexilate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva Pharms USA Dabigatran Etexilate Sales Growth Rate (2012-2017)
Figure Teva Pharms USA Dabigatran Etexilate Sales Market Share in United States (2012-2017)
Figure Teva Pharms USA Dabigatran Etexilate Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Dabigatran Etexilate
Figure Manufacturing Process Analysis of Dabigatran Etexilate
Figure Dabigatran Etexilate Industrial Chain Analysis
Table Raw Materials Sources of Dabigatran Etexilate Major Players/Suppliers in 2016
Table Major Buyers of Dabigatran Etexilate
Table Distributors/Traders List
Figure United States Dabigatran Etexilate Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Dabigatran Etexilate Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Dabigatran Etexilate Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Dabigatran Etexilate Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Dabigatran Etexilate Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Dabigatran Etexilate Sales Volume (K Units) Forecast by Type in 2022
Table United States Dabigatran Etexilate Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Dabigatran Etexilate Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Dabigatran Etexilate Sales Volume (K Units) Forecast by Application in 2022
Table United States Dabigatran Etexilate Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Dabigatran Etexilate Sales Volume Share Forecast by Region (2017-2022)
Figure United States Dabigatran Etexilate Sales Volume Share Forecast by Region (2017-2022)
Figure United States Dabigatran Etexilate Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources